THIOGUANINE ANHYDROUS
Adult T Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)Small moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
20 Active assets in the Adult T Acute Lymphoblastic Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE National Cancer Institute (NCI) | Phase 3 | BB |
PREDNISONE TABLETS National Cancer Institute (NCI) | Phase 3 | BB |
Inno-206 National Cancer Institute (NCI) | Phase 3 | BB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 3 | BB |
VINCRISTINE SULFATE National Cancer Institute (NCI) | Phase 3 | BB |
View all 25 →
Same molecule, other indications
THIOGUANINE ANHYDROUS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →